Nvidia B200s to power SK Biopharma AI drug research
Tech in Asiaen
SK Biopharmaceuticals President Lee Dong-hoon said AI will be an important factor in competitiveness in new drug development.
This is a short summary published by AI Global Wire. The full article is owned and hosted by Tech in Asia — open it there to read it in full.
Read the full story at Tech in Asia- Forskning
Related AI news
- New AI models, critical threshold, and a design debate: A busy day for AI industryEconomic Times Tech · September 3, 2026
- Beyond Outcome Gaps: Process-Aware Fairness Diagnosis for LLM-based Multi-Agent Decision SystemsarXiv cs.AI · September 3, 2026
- MASkills: Continual Skills Optimization for Multi-Agent LLM SystemsarXiv cs.AI · September 3, 2026
- FUSE: An Evaluating Framework for Dangerous Capabilities of LLMsarXiv cs.AI · September 3, 2026
- When Can a Machine Trust a Statute? A Survival Certificate for Machine-Extracted Legal LogicarXiv cs.AI · September 3, 2026
- Benchmarking Language Models for Statistical Problem FormulationarXiv cs.AI · September 3, 2026